Lonza announced a CHF85m (93m USD) investment in its Capsules and Health Ingredients (CHI) Division, a dosage form delivery partner to the biopharma and health nutrition industry. The investment will enable the company to expand its overall production capacity of capsules within CHI’s Capsugel® portfolio by 30 billion capsules annually while maintaining the high-quality standards […]
The post Lonza Expands Its Capsule Manufacturing Capacity first appeared on World Pharma Today.
This post first appeared on Leading Pharmaceutical Industry Online Platform, please read the originial post: here